Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma

PURPOSE: To compare the efficacy and the tolerability of preservative-free Tafluprost 0.0015% (TP) vs Latanoprost 0.005% (LP) in patients with primary open-angle glaucoma (POAG). METHODS: Prospective, randomized, crossover study included patients with early POAG attending the outpatient clinic from...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagras, Sherein M, Al-Duwailah, Omar KH, Nassief, Mona A, Abdelhameed, Ameera G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Special Focus, Glaucoma, Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544051/
https://www.ncbi.nlm.nih.gov/pubmed/34427247
http://dx.doi.org/10.4103/ijo.IJO_165_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544051/
https://www.ncbi.nlm.nih.gov/pubmed/34427247
http://dx.doi.org/10.4103/ijo.IJO_165_21

Ejemplares similares